データなし
データなし
As Of September 30, 2024 Autonomix Medical Had Cash Of $5.2M
オートノミクス・メディカル | 10-Q:四半期報告書
Autonomix Medical Launches Public Offering; Shares Drop
Autonomix Medical Reports New Topline Results From First 15 Patients' 7-Day Data Highlighting Significant Impact On Treatment Of Pancreatic Cancer Pain With Maintained Pain Reduction; 79% Responder Rate Achieved With Zero Opioid Use And Quality Of...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means From Lead-In Patients in Ongoing Human Clinical Trial
データなし
データなし